Febuxostat Tablet
Product Images NDC 51407-293

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Febuxostat (NDC 51407-293). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-293-30lb Febuxostat 40 mg Tabs.jpg (51407 293 30lb Febuxostat 40 mg Tabs)

This is a description for a medication called Febuxostat, which is produced by GSMS Incorporated. The package is NDC 51407-293-30, containing 30 tablets of 40mg each. The label on the bottle states that the medication should be kept at 20 to 25°C (68 to 77°F) and be protected from light. Children should not have access to the medicine, and the patient information leaflet should be included. The medication should not be used if the seal is broken or missing. Manufactured by Hikma Pharmaceuticals, the packaging is done in Camarilio, CA 93012 USA.*

FDA Label Image

51407-294-30lb Febuxostat 80 mg Tabs.jpg (51407 294 30lb Febuxostat 80 mg Tabs)

The text is a description of Febuxostat tablets including its NDC number, tablet strength, storage information, manufacturer and packaging details. It also highlights precautions such as not accepting the product if the seal is broken, protecting it from light and keeping it out of children's reach. It directs pharmacists to dispense the patient information leaflet with the drug. See package insert for dog dosage.*

FDA Label Image

Febuxostat Chemical Structure (Fcf23fa1 Bc2d 4cdf Bf25 51a9ee09fa0d 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.